English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

See articles by Scherer et al. [6] (pages 79–87) and Ochi et al. [12] (pages 88–96) in this issue .Small arteries play an important role for blood pressure regulation and blood flow distribution to different organs. The diameter of these vessels is under the control of a number of factors such as blood pressure, flow, conducted signals from neighboring vessel segments, diverse metabolites produced from surrounding tissues, transmitters liberated from nerve endings, substances released from the endothelium, and a variety of vasoactive compounds washed ashore by the blood stream. Among these factors, increasing attention is now being given to bioactive sphingolipid metabolites, especially sphingosine-1-phosphate (S1P).A number of comprehensive reviews have summarized the current knowledge about S1P (for example, [1–4]). Briefly, S1P plays an important role in such diverse processes as cell migration, growth, shape change, survival, and apoptosis. This allows S1P to contribute to different pathological conditions, for example transplant rejection, sepsis, cancer, immunity, wound healing, and ischemia/reperfusion as well as restenosis, angiogenesis, vascular permeability, and vasospasm. S1P is derived from membrane phospholipids by enzymatic breakdown of sphingomyelin upon cell stimulation. The amount of available S1P is regulated by its synthesis by sphingosine kinase and its degradation by S1P phosphatase or S1P lyase. S1P is a normal component of blood plasma, present at concentrations between 0.2 and 0.5 μmol/L. The concentration of S1P in serum is even higher because it is stored at high concentrations and is thought to be released from platelets and other blood cells as well as … * Tel.: +49 381 4948016; fax: +49 381 4948002. Email address: rudolf.schubert{at}medizin.uni-rostock.de

Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction?